Ekso Bionics Holdings Inc reports results for the quarter ended in March - Earnings Summary

Chronoscale

30/04/2024 02:39

* Ekso Bionics Holdings Inc  EKSO.OQ  reported a quarterly
adjusted loss of 20 cents​​ per share for the quarter ended in
March, higher than the same quarter last year, when the company
reported EPS of -33 cents.  The lone analyst forecast for the
quarter was for a loss of 16 cents per share. 
    * Revenue fell 8.9% to $3.76 million from a year ago;
analysts
expected $4.99 million. 
    * Ekso Bionics Holdings Inc's reported EPS for the quarter
was a
loss of 20 cents​.
    * The company reported a quarterly loss of $3.43 million.
    * Ekso Bionics Holdings Inc shares had fallen by 8.1% this
quarter and lost 50.0% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 128.6% in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "buy"

Wall Street's median 12-month price target for Ekso Bionics
Holdings Inc is $9.25 
This summary was machine generated from LSEG data April 30 at
01:39 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.11          -0.20          Missed
 Dec. 31 2023      -0.11          -0.22          Missed
 Sep. 30 2023      -0.31          -0.24          Beat
 Jun. 30 2023      -0.28          -0.31          Missed